Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FU4U1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,340
Award facts
- Contract value 100% obligated
- $39,340.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $39,340.39 on April 25, 2025, for the supply of Wegovy 2.4 mg/0.75 mL pens with an ultimate completion date of April 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive federal contract portfolio encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Wegovy, an injectable GLP-1 receptor agonist used for weight management, reflects the company's ongoing role in supplying specialized pharmaceutical products to support Defense Health Agency and other federal healthcare programs through the DLA's global pharmaceutical support infrastructure.
Quick answers
Who was awarded contract SPE2DB25FU4U1?
SPE2DB25FU4U1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 25, 2025.
How much is contract SPE2DB25FU4U1 worth?
The government has obligated $39,340 on SPE2DB25FU4U1.
Is contract SPE2DB25FU4U1 an order under another contract?
Yes. SPE2DB25FU4U1 is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FU4U1 competed?
The extent of competition for SPE2DB25FU4U1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award